Lynx Financial

Lynx Financial does not develop drugs or devices itself but invests in/employs advisory roles for innovative healthcare/life science companies at various stages from preclinical through clinical development. For example: co-led Series A financing for Aurealis Therapeutics (cell/gene therapy in Phase 2 for diabetic foot ulcer); strategic partnership with Bone Index Finland Ltd., a medtech company with FDA-approved diagnostic device. Lynx Financial is an active boutique investment banking/investment management company specializing exclusively in healthcare/life sciences/medical technology sectors—with particular expertise facilitating cross-border transactions between Western innovators and Chinese capital/resources. It does not develop drugs or devices itself, but acts as financial advisor/investor/co-lead on financings, supports commercial expansion efforts, and provides strategic guidance to medtech startups entering new markets.